𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Novel targeted agents for platelet-derived growth factor receptor and c-KIT in malignant gliomas

✍ Scribed by Patrick G. Morris; Lauren E. Abrey

Book ID
107384398
Publisher
Springer-Verlag
Year
2010
Tongue
English
Weight
394 KB
Volume
5
Category
Article
ISSN
1776-2596

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Expression of c-ABL, c-KIT, and platelet
Expression of c-ABL, c-KIT, and platelet-derived growth factor receptor-β in ovarian serous carcinoma and normal ovarian surface epithelium
✍ Rosemarie E. Schmandt; Russell Broaddus; Karen H. Lu; Hyun Shvartsman; Angela Th 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 270 KB

## Abstract ## BACKGROUND Tyrosine kinases, such as c‐KIT, c‐ABL, and platelet‐derived growth factor‐beta (PDGFR‐β), are important regulators of cell growth. Highly potent and selective inhibitors of tyrosine kinases are being investigated as alternatives to standard chemotherapy. One such inhibit

9p21 locus analysis in high-risk gastroi
9p21 locus analysis in high-risk gastrointestinal stromal tumors characterized for c-kit and platelet-derived growth factor receptor α gene alterations
✍ Federica Perrone; Elena Tamborini; Gian Paolo Dagrada; Federica Colombo; Lorena 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 248 KB

## Abstract ## BACKGROUND Gastrointestinal stromal tumors (GISTs) are noncomplex sarcomas that often are due to __c‐kit__‐activating and platelet‐derived growth factor receptor α gene (__PDGFRα__)‐activating mutations and perturbations of their related signaling pathways. Molecular and cytogenetic

Platelet-derived growth factor receptor
Platelet-derived growth factor receptor as a prognostic marker and a therapeutic target for imatinib mesylate therapy in osteosarcoma
✍ Tadahiko Kubo; Sajida Piperdi; Jeremy Rosenblum; Cristina R. Antonescu; Wen Chen 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 474 KB 👁 2 views

## Abstract The purpose of this review was to determine whether imatinib mesylate (STI571, Gleevec) has a role in the treatment of osteosarcoma. The expression of platelet‐derived growth factor (PDGF) receptor and its ligand was examined in a panel of surgical specimens obtained from 54 osteosarcom